These tumors can form spontaneously, for no known reason, or they may develop because of a faulty gene (mutation). Pheochromocytomas and paragangliomas are usually benign (noncancerous), but they can ...

Please provide your email address to receive an email when new articles are posted on . Adults with pheochromocytoma or paraganglioma are nearly five times more likely to experience a vertebral ...

Pheochromocytoma fascinates and, at times, confounds clinicians. The symptoms due to hypersecretion of catecholamines can mimic more than 30 medical disorders. 1 This rare tumor can be lethal if left ...

Background A 40-year-old man was referred to our clinic with recurrent paragangliomas. He had undergone resection of a paraganglioma superior to the right adrenal gland at 19 years of age, resection ...

Welireg is the first FDA-approved oral therapy for PPGL, based on the LITESPARK-015 trial results. The trial showed a 26% overall response rate, with responses lasting a median of 20.4 months. Common ...

Paraganglioma is a rare tumor of neural crest origin, usually considered as benign with the potential to metastasize and the incidence of malignancy of about 10%. Although the majority of these tumors ...

Patient-Oncologist Alliance, Psychosocial Well-Being, and Treatment Adherence Among Young Adults With Advanced Cancer The occurrence of ≥ two distinct types of tumors, one of them paraganglioma (PGL), ...

Here, we report the case of a 54-year-old man with an inoperable metastatic paraganglioma in whom systemic targeted radiotherapy with 177 Lu-Dotatate was indicated. He had hypertension and tachycardia ...

Certain kinds of tumors can be inherited within families. Identifying the underlying genetic cause is important in treatment, but most studies on these tumors have been carried out on Caucasian ...

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for belzutifan for the treatment of adult and pediatric patients aged 12 years and ...

Ahead of Rare Disease Day, here is what you need to know about pheochromocytoma and paraganglioma, two rare types of tumors. Ahead of Rare Disease Day, here is what you need to know about two rare ...

Findings showed an ORR of 26% (95% CI, 17-38), with a median duration of response of 20.4 months (95% CI, 8.3, not reached). The Food and Drug Administration (FDA) has approved Welireg ™ (belzutifan) ...